While presenting at a symposium held during the 3rd meeting of the European and African Division of the International Society of Haemtology, Dr Rizza stated that the Directors of UK haemophilia centres were "involved in a very active programme of research, including a review of the incidence of hepatitis and factor VIII antibodies in haemophiliacs, a trial of prophylactic treatment, and a survey of home therapy."